MYASTHENIA GRAVIS, DIAGNOSIS AND TREATMENT

  • A.A Gde Agung Anom Arie W
  • Made Oka Adnyana
  • I Putu Eka Widyadharma

Abstract

Myasthenia gravis is one characteristic of autoimmune disease caused by the disruption of synaptic transmission at the neuromuscular junction. It is characterized by a progressive weakness and abnormal skeletal muscle used continuously and accompanied by fatigue on exertion. knowledge of normal anatomy and function of the neuromuscular junction is very important for understanding about myasthenia gravis,.Presynaptic membrane (membrane nerve), post-synaptic membrane (membrane of the muscle), and the synaptic gap forming part of the neuromuscular junction. Immunogenic mechanism plays a very important in the pathophysiology of myasthenia gravis, in which the antibody is the product of B cells is precisely against the acetylcholine receptor. Management of myasthenia gravis to do with drugs, thymomectomy or with immunomodulating and immunosuppressive therapy that can provide a good prognosis in the healing myasthenia gravis.

Downloads

Download data is not yet available.

Author Biographies

A.A Gde Agung Anom Arie W

Mahasiswa Fakultas Kedokteran Universitas Udayana

Made Oka Adnyana

Bagian/SMF Ilmu Penyakit Saraf Fakultas Kedokteran

Universitas Udayana/RumahSakit Umum Pusat Sanglah Denpasar

I Putu Eka Widyadharma

Bagian/SMF Ilmu Penyakit Saraf Fakultas Kedokteran

Universitas Udayana/RumahSakit Umum Pusat Sanglah Denpasar

How to Cite
ANOM ARIE W, A.A Gde Agung; ADNYANA, Made Oka; WIDYADHARMA, I Putu Eka. MYASTHENIA GRAVIS, DIAGNOSIS AND TREATMENT. E-Jurnal Medika Udayana, [S.l.], p. 1012-1035, may 2013. ISSN 2303-1395. Available at: <https://ojs.unud.ac.id/index.php/eum/article/view/5622>. Date accessed: 29 june 2022.

Keywords

Myasthenia gravis, Neuromuscular junction, Management

Most read articles by the same author(s)